IDNA icon

iShares Genomics Immunology and Healthcare ETF
IDNA

Overview Fund Activity

75 hedge funds and large institutions have $46.2M invested in iShares Genomics Immunology and Healthcare ETF in 2022 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 13 increasing their positions, 24 reducing their positions, and 6 closing their positions.

Holders
75
Holders Change
+9
Holders Change %
+13.64%
% of All Funds
1.21%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
19
Increased
13
Reduced
24
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Bank of America
1
Bank of America
North Carolina
$4.73M
2
Jane Street
2
Jane Street
New York
$2.12M
3
WAP
3
Wealthcare Advisory Partners
Pennsylvania
$5.48M
4
Janney Montgomery Scott
4
Janney Montgomery Scott
Pennsylvania
$1.03M
5
Envestnet Asset Management
5
Envestnet Asset Management
Illinois
$573K

Top Sellers

1
WBG
1
Wharton Business Group
Pennsylvania
$3.91M
2
UBS Group
2
UBS Group
Switzerland
$2.9M
3
Commonwealth Equity Services
3
Commonwealth Equity Services
Massachusetts
$1.98M
4
Citadel Advisors
4
Citadel Advisors
Florida
$394K
5
KAS
5
Kestra Advisory Services
Texas
$892K
Name Market Value Shares Shares
Change 		Shares
Change %
FTUS
76
Flow Traders U.S.
New York
– – -11,470 Closed
RJA
77
Raymond James & Associates
Florida
– – -8,729 Closed
OWM
78
Opes Wealth Management
California
– – -7,595 Closed
HBW
79
Hazlett, Burt & Watson
West Virginia
– – -845 Closed
WAM
80
Worth Asset Management
Texas
– – -100 Closed
VNA
81
Valley National Advisers
Pennsylvania
– – -32 Closed
CFGS
82
Concourse Financial Group Securities
Alabama
– – – –
EIP
83
Ellis Investment Partners
Pennsylvania
– – – –
1 2 3
4